Skip to content

The Prevalence of Rheumatic Heart Disease in School Children in Fiji

The Prevalence of Rheumatic Heart Disease in School Children in Fiji

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00779662
Enrollment
2000
Registered
2008-10-24
Start date
2008-02-29
Completion date
2008-12-31
Last updated
2008-10-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Rheumatic Heart Disease

Keywords

Rheumatic Heart Disease, Streptococcus, Fiji

Brief summary

This study is an epidemiological observational cross-sectional study designed to estimate the prevalence of echocardiographically confirmed RHD in school children from 5-14 years of age in Fiji. The study will be conducted in the Central Division of Fiji within a selection of up to16 primary schools located in the Korovou/Tailevu and Rewa/Nausori sub-divisions. School children will be enrolled after informed consent has been obtained. A standard cardiac examination (auscultation) will be performed as part of the routine annual health check by both school nurses, who have attended a training workshop, and by a paediatrician. All children with or without murmur will have a screening echocardiogram performed at a subsequent visit. Children found to have possible, probable or definite RHD or other cardiac pathology on the screening echocardiogram, will have a full echocardiogram performed by the echocardiography technician at the time of the second study visit. They will all also be referred to a paediatric cardiologist for further investigation and management and monitoring . Cases of RHD will be referred to and followed up by the National Fiji RHD register based at CWMH in Suva.

Interventions

None listed

Sponsors

National Institute of Allergy and Infectious Diseases (NIAID)
CollaboratorNIH
Menzies School of Health Research
CollaboratorOTHER
University of Melbourne
CollaboratorOTHER
Queensland Institute of Medical Research
Lead SponsorOTHER

Study design

Observational model
ECOLOGIC_OR_COMMUNITY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
5 Years to 14 Years
Healthy volunteers
Yes

Inclusion criteria

* Informed consent will be obtained for all participants * All children between the ages of 5-14 Years are eligible for the study.

Exclusion criteria

* None

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026